BARCLAYS PLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 59 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$75
-50.7%
10,151
-47.6%
0.00%
Q1 2024$152
-20.8%
19,369
-48.6%
0.00%
Q4 2023$192
+611.1%
37,716
+710.7%
0.00%
Q3 2023$27
-30.8%
4,652
-10.3%
0.00%
Q2 2023$39
-92.6%
5,185
-90.7%
0.00%
Q1 2023$52655,6620.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 793,170$7,686,0000.94%
Sio Capital Management, LLC 189,062$1,832,0000.36%
J. Goldman & Co LP 168,749$1,635,0000.11%
Rubric Capital Management LP 57,518$557,0000.05%
GSA CAPITAL PARTNERS LLP 13,823$134,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 66,899$648,0000.02%
PDT Partners, LLC 11,539$112,0000.01%
Global Financial Private Client, LLC 266$2,4840.00%
Hartford Financial Management Inc. 598$6,0000.00%
FIRST TRUST ADVISORS LP 34,353$333,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders